Skip to main content
. Author manuscript; available in PMC: 2017 May 26.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 14;1036-1037:170–177. doi: 10.1016/j.jchromb.2016.09.018

Fig. 7.

Fig. 7

24 h urinary 2,8-dihydroxyadenine (DHA) excretion in 3 patients with APRT deficiency who were not receiving treatment with a xanthine dehydrogenase inhibitor. Patient 1, 2 and 3 correspond to c, d and e in Fig. 5, respectively. Data represents mean values and SD of six measurements by the UPLC–MS/MS assay.